Milestone Pharmaceuticals Inc.

NasdaqGS:MIST Stock Report

Market Cap: US$87.7m

Milestone Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:MIST Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Nov 23BuyUS$2,374,117Alta Fundamental Advisers LLCCompany773,328US$3.07

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of MIST?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders503,0130.76%
Institutions31,634,50147.8%
General Public34,018,24151.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 54.1%.


Top Shareholders

Top 25 shareholders own 47.82% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.51%
BlackRock, Inc.
4,971,344US$6.6m52%no data
4.92%
RTW Investments, LP
3,256,102US$4.3m0%0.07%
4.32%
Millennium Management LLC
2,855,612US$3.8m91.1%no data
3.58%
Alta Fundamental Advisers LLC
2,371,289US$3.1m41.9%1.4%
3.48%
Lion Point Capital, LP
2,300,207US$3.0m39.4%9.61%
3.43%
Citadel Advisors LLC
2,272,404US$3.0m867%no data
3.02%
OrbiMed Advisors LLC
2,000,000US$2.7m0%0.04%
2.65%
Nantahala Capital Management, LLC
1,750,000US$2.3m0%0.25%
2.21%
Stonepine Capital Management LLC
1,462,296US$1.9m0%0.88%
2.05%
Goldman Sachs Group, Investment Banking and Securities Investments
1,353,067US$1.8m0%no data
2%
Bleichroeder LP
1,326,085US$1.8m0%0.46%
1.83%
Altium Capital Management LP
1,212,882US$1.6m0%0.78%
1.24%
Morgan Stanley, Investment Banking and Brokerage Investments
819,828US$1.1m18.9%no data
0.98%
Velan Capital Partners LP
650,000US$861.3k0%0.46%
0.92%
BML Capital Management, LLC
606,145US$803.1k37%0.53%
0.76%
Monashee Investment Management, LLC
500,000US$662.5k0%0.08%
0.7%
Ikarian Capital, LLC
466,019US$617.5k0.69%0.21%
0.47%
Tavistock Life Sciences
309,007US$409.4k0%0.02%
0.43%
Joseph Oliveto
285,176US$377.9k0.19%no data
0.41%
BMO Asset Management Corp.
273,100US$361.9k0%no data
0.31%
ADAR1 Capital Management, LLC
202,460US$268.3k0%0.08%
0.22%
HANSAINVEST Hanseatische Investment-GmbH
147,276US$195.1k0%0.01%
0.2%
Lorenz Muller
133,386US$176.7k0%no data
0.091%
Ancora Advisors LLC
60,000US$79.5k20%no data
0.078%
Envestnet Asset Management, Inc.
51,833US$68.7k151%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.